• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Optimi Health Corp. - Common Shares (NQ:OPTH)

3.330 UNCHANGED
Delayed Quote Updated: 3:57 PM EDT, Oct 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 87
Open 3.330
Bid (Size) 3.010 (500)
Ask (Size) 5.000 (300)
Prev. Close 3.330
Today's Range 3.330 - 3.330
52wk Range 3.040 - 6.400
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Plans Phase 3 MDMA-Assisted Therapy Trial for PTSD
September 16, 2026
Via Investor Brand Network
NetworkNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Plans Phase 2 Psilocybin Trial for Major Depressive Disorder
September 10, 2026
Via Investor Brand Network

Performance

52-Week Range 48.0% below 52-week high
3.330
3.0452W Low 6.4052W High
1 Week 11.0% below 1-week high
3.041W Low 3.741W High

Optimi Health Corp. - Common Shares (OPTH) traded between $3.04 and $6.40 over the past 52 weeks and last traded at $3.33, 48.0% below its 52-week high. Over the past week it ranged between $3.04 and $3.74.

Past 12 Months
-4.9%
-31.2%
-30.5%
-45.2%
-45.2%
-45.2%
1W -$0.17
1M -$1.51
3M -$1.46
6M -$2.75
YTD -$2.75
1Y -$2.75

OPTH was -45.2% over the past year, -45.2% over six months, -45.2% year to date, -4.9% in the last week.

12 Months vs Market
OPTH
-45.2%
DIA
+11.1%
SPY
+14.2%
QQQ
+17.5%
IWM
+9.3%

Over the past 12 months OPTH returned -45.2% versus DIA (Dow) +11.1%, SPY (S&P 500) +14.2%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +9.3%.

Volume & Liquidity 0.00× 3-mo avg
Today 87 3-mo avg 39.2K
1W
32.6K
1M
33.5K
3M
39.2K
6M
105.0K
YTD
105.0K
1Y
105.0K

OPTH most recently traded 87 shares against a 3-month average daily volume of 39.2K.

More News

Read More
InvestorNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Completes First Psilocybin Export to United Kingdom for Planned Phase 2 Trial
June 10, 2026
Via Investor Brand Network
Topics Supply Chain
News headline image
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
June 10, 2026
From OPTIMI HEALTH CORP.
Via GlobeNewswire
BioMedNewsBreaks — Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Advances Ibogaine Drug Development Program
June 08, 2026
Via Investor Brand Network
News headline image
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
June 08, 2026
From OPTIMI HEALTH CORP.
Via GlobeNewswire
BioMedNewsBreaks — Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Completes GMP Production Run of 5mg Psilocybin Drug Product
June 02, 2026
Via Investor Brand Network
News headline image
Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia
June 02, 2026
From OPTIMI HEALTH CORP.
Via GlobeNewswire
NetworkNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Highlights Australia Psychedelic Therapy Expansion Following TGA Framework Update
May 29, 2026
Via Investor Brand Network
News headline image
Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia
May 29, 2026
From OPTIMI HEALTH CORP.
Via GlobeNewswire
PsychedelicNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Featured in Diamond Equity Research Initiation Report Highlighting Commercial Psychedelics Opportunity
May 27, 2026
Via Investor Brand Network
InvestorNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Prices $15 Million Public Offering in Connection With Nasdaq Uplisting
May 21, 2026
Via Investor Brand Network
News headline image
Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting
May 20, 2026
Via PressReach
Topics Regulatory Compliance

Frequently Asked Questions

Is Optimi Health Corp. - Common Shares publicly traded?
Yes, Optimi Health Corp. - Common Shares is publicly traded.
What exchange does Optimi Health Corp. - Common Shares trade on?
Optimi Health Corp. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Optimi Health Corp. - Common Shares?
The ticker symbol for Optimi Health Corp. - Common Shares is OPTH on the Nasdaq Stock Market
What is the current price of Optimi Health Corp. - Common Shares?
The current price of Optimi Health Corp. - Common Shares is 3.330
When was Optimi Health Corp. - Common Shares last traded?
The last trade of Optimi Health Corp. - Common Shares was at 10/19/26 03:57 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap